other material
confidence high
sentiment neutral
materiality 0.70
Eledon exchanges 550K common for Series X1 preferred; convertible at 55.56 per share
Eledon Pharmaceuticals, Inc.
- Exchanged 550,000 common shares for 9,899.99 Series X1 preferred shares with BVF entities.
- Series X1 preferred convertible into ~6.55M shares at 55.5556 common per preferred (post-reverse split).
- After exchange, common outstanding: 13,756,788; Series X1 preferred outstanding: ~117,970 shares.
- Exchange exempt under Section 3(a)(9) of Securities Act; no registration required.